ElizabethMarySwisherMD

Gynecologic Oncology

Associate Professor of Obstetrics & Gynecology, University Wash

Overview of Dr. Swisher

Dr. Elizabeth Swisher is an obstetrician/gynecologist in Seattle, WA and is affiliated with multiple hospitals in the area, including UW Medicine/University of Washington Medical Center, Seattle Children's Hospital, and Fred Hutch Cancer Center. She received her medical degree from University of California San Diego School of Medicine and has been in practice 25 years. Dr. Swisher accepts several types of health insurance, listed below. She is one of 20 doctors at Seattle Children's Hospital and one of 168 doctors at UW Medicine/University of Washington Medical Center who specialize in Obstetrics & Gynecology. She has more than 100 publications and over 500 citings.

Office
University of Washington Medical Center
1959 NE Pacific St
Seattle, WA 98195
Book by Phone+1(415) 413-2388

Education & Training

University of WashingtonResidency, Obstetrics and Gynecology, 1992 - 1996
University of California San Diego School of MedicineClass of 1992

Certifications & Licensure

WA State Medical License 1992 - 2025
OR State Medical License 2020 - 2022
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer) Start of enrollment: 2009 Oct 01
Completed
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study Start of enrollment: 2011 Dec 01
Completed
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families Start of enrollment: 2013 Apr 01
Completed
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer Start of enrollment: 2020 Aug 11
TERMINATED
PHASE1, PHASE2
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2021 Oct 18
RECRUITING
PHASE1
Join now to see all

Publications & Presentations

PubMed

Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics: A Cluster Randomized Clinical Trial.
Elizabeth M Swisher, Heather M Harris, Sarah Knerr, Tesla N Theoryn, Barbara M Norquist
JAMA Network Open. 2025-03-03
Farletuzumab ecteribulin and MORAb-109, folate receptor alpha and mesothelin targeting antibody-drug conjugates, show activity in poor prognosis gynaecological cancer ...
Ksenija Nesic, Katherine Rybinski, Gayanie Ratnayake, Gwo-Yaw Ho, Ratana Lim
Clinical and Translational Medicine. 2025-03-01
Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access.
Ann Oluloro, Elizabeth M Swisher, Heidi J Gray, Barbara Goff, Kemi M Doll
Journal of the National Cancer Institute. 2024-12-19

Journal Articles

Methylation of All BRCA1 Copies Predicts Response to the PARP Inhibitor Rucaparib in Ovarian Carcinoma
Scott H Kaufmann, Elizabeth M Swisher, Nature

Press Mentions

Improving Cancer-Susceptibility Gene Detection in Primary Care: Insights from Swisher Et Al. StudyMarch 11th, 2025
New Initiative Aims to Enhance Cancer Gene Testing in Primary Care SettingsMarch 7th, 2025
Racial Disparities in the Risk of Ovarian Cancer for Patients with Fibroids and EndometriosisMay 12th, 2023
Join now to see all

Grant Support

Clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancerUNIVERSITY OF WASHINGTON2023–2028
Combined Methylation and Mutation to Predict Response to PARP InhibitorsUNIVERSITY OF WASHINGTON2020–2025
Implementing the moon: Getting genomic testing to the publicUNIVERSITY OF WASHINGTON2019–2025
Implementing the moon: Getting genomic testing to the publicUNIVERSITY OF WASHINGTON2019–2025
Implementing the moon: Getting genomic testing to the publicUNIVERSITY OF WASHINGTON2019–2025
Defining A Pre-Malignant Phenotype In Fallopian Tube EpitheliumNational Cancer Institute2009–2012
Clinical Implication Of The Acquisition Of BRCA1/2 Function In Brca1/2-DeflcientNational Cancer Institute2009–2011
Genetic And Epigenetic Markers In Ovarian CancerNational Cancer Institute2002–2006

Professional Memberships

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
First Health PPO
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
ODS Network
Premera BCBS Heritage & Heritage Plus 1
Providence Health System Personal Option
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment